ScholarIQanswers from OpenAlex & ORCID
Marisa Dolled‐Filhart
ResearcherPublications, citations & collaboration network
Marisa Dolled‐Filhart is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Marisa Dolled‐Filhart have?
ScholarIQindexed works
Marisa Dolled‐Filhart has 105 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Marisa Dolled‐Filhart have?
ScholarIQcitation count
Marisa Dolled‐Filhart has 22,994 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Marisa Dolled‐Filhart?
ScholarIQh-index
Marisa Dolled‐Filhart has an h-index of 39 in OpenAlex.
What is the i10-index of Marisa Dolled‐Filhart?
ScholarIQi10-index
Marisa Dolled‐Filhart has an i10-index of 57 in OpenAlex.
What is the OpenAlex record for Marisa Dolled‐Filhart?
ScholarIQopenalex
The OpenAlex for Marisa Dolled‐Filhart is on the source record.
What are the most-cited papers on Marisa Dolled‐Filhart?
ScholarIQmost cited works
Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
Roy S. Herbst, Paul Baas, Dong‐Wan Kim, Enriqueta Felip, José Luis Perez‐Gracia, Ji‐Youn Han, Julian R. Molina, Joo-Hang Kim, Catherine Dubos Arvis, Myung‐Ju Ahn, Margarita Majem, Mary J. Fidler, Gilberto de Castro, Marcelo Garrido, Gregory M. Lubiniecki, Yue Shentu, Ellie Im, Marisa Dolled‐Filhart, Edward B. Garon
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Edward B. Garon, Naiyer A. Rizvi, Rina Hui, Natasha B. Leighl, Ani Sarkis Balmanoukian, Joseph P. Eder, Amita Patnaik, Charu Aggarwal, Matthew A. Gubens, Leora Horn, Enric Carcereny, Myung‐Ju Ahn, Enriqueta Felip, Jong-Seok Lee, Matthew D. Hellmann, Omid Hamid, Jonathan W. Goldman, Jean‐Charles Soria, Marisa Dolled‐Filhart, Ruth Z. Rutledge, Jin Zhang, Jared Lunceford, Reshma Rangwala, Gregory M. Lubiniecki, Charlotte Roach, Kenneth Emancipator, Leena Gandhi
Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort
Laura Q.M. Chow, Robert I. Haddad, Shilpa Gupta, Amit Mahipal, Ranee Mehra, Makoto Tahara, Raanan Berger, Joseph P. Eder, Barbara Burtness, Se‐Hoon Lee, Bhumsuk Keam, Hyunseok Kang, Kei Muro, Jared Weiss, Ravit Geva, Chia‐Chi Lin, Hyun Cheol Chung, Amy Meister, Marisa Dolled‐Filhart, Kumudu Pathiraja, Jonathan D. Cheng, Tanguy Y. Seiwert
Prognostic Significance of PD-L1 in Patients with Non–Small Cell Lung Cancer: A Large Cohort Study of Surgically Resected Cases
Jong‐Mu Sun, Wei Zhou, Yoon‐La Choi, So‐Jung Choi, Se Eun Kim, Zhen Wang, Marisa Dolled‐Filhart, Kenneth Emancipator, Dianna Wu, Russell Weiner, Dennis M. Frisman, Hong Kwan Kim, Yong Soo Choi, Young Mog Shim, Jhingook Kim